A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma

A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma

Patients with advanced stomach adenocarcinoma (STAD) commonly show high mortality and poor prognosis. Increasing evidence has suggested that basic metabolic changes may promote the growth and aggressiveness of STAD; therefore, identification of metabolic prognostic signatures in STAD would be meanin...

Full description

Bibliographic Details
Main Authors: Zaisheng Ye, Miao Zheng, Yi Zeng, Shenghong Wei, He Huang, Yi Wang, Qinying Liu, Zhitao Lin, Shu Chen, Qiuhong Zheng, Luchuan Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
stomach adenocarcinoma
metabolism-based prognostic signature
clinical characteristics
tumor microenvironment
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.612952/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.612952/full

Similar Items